Art

J-GLOBAL ID：200902266612331709   Reference number：08A0469294

肝がんの外科的治療と再発治療の変遷

Author (1)： YAGI TAKAHITO (岡山大 医・歯 病院 肝胆膵外科)
Material： 岡山医学会雑誌  (Journal of Okayama Medical Association)
Volume： 120  Issue： 1  Page： 63-67  Publication year： May. 01, 2008 
JST Material Number： Z0158B  ISSN： 0030-1558  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human(primates) ,...
Semi thesaurus term： radiofrequency ablation

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0469294&from=J-GLOBAL&jstjournalNo=Z0158B") }}

JST classification (2)： Treatment for tumors in general  (GE03031L) ,  Surgical treatment for tumors  (GE03033T)

Reference (11)：

• VIVARELLI, M. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg. 2004, 240, 102-107
• MACHI, J. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg. 2005, 29, 1364-1373
• O'NEIL, BH. Hepatocellular carcinoma : the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy. Oncologist. 2007, 12, 1425-1432
• HOPFNER, M. Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. World J Gastroenterol. 2008, 14, 1-14
• PAESHUYSE, J. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Hepatology. 2006, 43, 761-770

Terms in the title (4)： 肝がん ,  外科的治療 ,  再発 ,  治療